1-3 of 3
Rainer Haas, MD, Prof
Close
Sort by
Journal Articles

Phase II Study of Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) As First Salvage Therapy in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Final Results From the AZARELA-Trial (NCT-00795548)

Thomas Schroeder, MD, Akos Czibere, MD, PhD, Nicolaus Kröger, Uwe Platzbecker, MD, Gesine Bug, Lutz Uharek, Prof., Dr., Thomas Luft, Christine Wolschke, Ingmar Bruns, MD, Fabian Zohren, MD, Roland Fenk, Rainer Haas, MD, Prof, Guido Kobbe, MD
Journal: Blood
Blood (2011) 118 (21): 656.
https://doi.org/10.1182/blood.V118.21.656.656
Published: 2011
Journal Articles

Secondary Primary Malignancies in Patients with Multiple Myeloma Treated with High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation,

Roland Fenk, MD, Florian Neubauer, Ingmar Bruns, MD, Christian Saure, MD, Thomas Schroeder, MD, Ulrich Germing, MD, Norbert Gattermann, MD, Rainer Haas, MD, Prof, Guido Kobbe, MD
Journal: Blood
Blood (2011) 118 (21): 4087.
https://doi.org/10.1182/blood.V118.21.4087.4087
Published: 2011
Journal Articles

Reapplication of High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation as Salvage Treatment for Patients with Relapsed or Refractory Multiple Myeloma – a Single Center Experience.

Roland Fenk, MD, PhD, Vanessa Liese, Ingmar Bruns, MD, PhD, Mustafa Kondakci, MD, Sebastian Balleisen, MD, Christian Saure, Thomas Schröder, MD, Rainer Haas, MD, Prof, Guido Kobbe, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3418.
https://doi.org/10.1182/blood.V114.22.3418.3418
Published: 2009